Mostra el registre parcial de l'element
dc.contributor.author | Abdullah, Mustafa Jamel | es |
dc.date.accessioned | 2015-02-26T12:37:11Z | |
dc.date.available | 2015-02-26T12:37:11Z | |
dc.date.issued | 2015 | es |
dc.identifier.citation | Abdullah, Mustafa Jamel. Prevalence of xerostomia in patients attending Shorish dental speciality in Sulaimani city. En: Journal of Clinical and Experimental Dentistry, 2015, Vol. 7, No. 1: 45-53 | es |
dc.identifier.uri | http://hdl.handle.net/10550/42395 | |
dc.description.abstract | Objectives: The aim of this study was to investigate the prevalence of xerostomia among dental patients and explo - re the possible risk factors and symptoms associated with this condition. Study Design: The prevalence of xerostomia and its associations were investigated among patients (n=1132) who were visiting the department of oral medicine at shorish dental speciality in sulaimani city. The age range was bet - ween 10-79 years. 512 (45.2%) of participants were males and 620 (54.8%) were females. The data collected were age, sex, systemic diseases, medications and habit of smoking. Logistic regression models to estimate odds ratios and 95% confidence intervals were used to investigate the association of xerostomia with age, systemic diseases and medications and Chi Square test was also used to analyze the data. Results: Prevalence of xerostomia was 16.07%. Prevalence of xerostomia was significantly higher among females (19.51%) than males (11.91%) ( P =0.001). The most common diseases with the highest prevalence of xerostomia were psychological disorders (57.14%) followed by diabetes mellitus (53.84%), neurological disorders (40%), thyroid disorders (37.5%) and hypertension (36.48%). The most common medication with the highest prevalen - ce of xerostomia was antihistamine (66.66%) followed by psychotherapeutic medications (60%), pain medica - tions (55.88%), endocrinologic agents (51.21%), antidyslipidic agents (50%) and antihypertensive medication (38.98%). Xerostomia was significantly associated with ageing (OR: 1.02, P =0.000), systemic diseases (OR: 2.80, P =0.000) and medications (OR: 5.17, P =0.000). There was a high prevalence of reported symptoms of xerostomia and these symptoms were more prevalent among females, prevalence of xerostomia was higher in heavy smoker patients (19.48%) than non smoker patients but not significantly (16.14%) ( p = 0.44). Conclusions: There was a high prevalence of xerostomia among dental patients; xerostomia was significantly more prevalent among females and significantly associated with age, systemic diseases and medications; xerostomia adversely affects oral functions; dentist must be familial with sign and symptoms of xerostomia and can have an active role in the management of xerostomia and preventing or treating complications. | en_US |
dc.subject | Odontología | es |
dc.subject | Ciencias de la salud | es |
dc.title | Prevalence of xerostomia in patients attending Shorish dental speciality in Sulaimani city | es |
dc.type | journal article | es_ES |
dc.subject.unesco | UNESCO::CIENCIAS MÉDICAS | es |
dc.type.hasVersion | VoR | es_ES |